Brand Name: JAYPIRCA Generic Name: pirtobrutinib JAYPIRCA (pirtobrutinib) is used for treatment of Adult patients with relapsed or refractory mantle cell lymphoma (MCL)
Jaypirca is a cancer medicine used to treat adults with mantle cell lymphoma (a cancer of B cells, a type of white blood cell) whose cancer has come back (relapsed) or no longer responds to treatment (refractory), and who had previously received a type of cancer medicine called a Bruton’s tyrosine kinase (BTK) inhibitor.
| Brand Name: | JAYPIRCA |
| Generic Name: | pirtobrutinib |
| Strength: | Tablets: 50 mg, 100 mg |
| Manufacturer: | Eli Lilly and Company |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “JAYPIRCA (pirtobrutinib)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for JAYPIRCA (pirtobrutinib) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
